Skip to main content
SpringerLink
Log in

Occurrence and predictive factors of restenosis in coronary heart disease patients underwent sirolimus-eluting stent implantation

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Background

This study aimed to investigate the occurrence and predictive factors of restenosis in coronary heart disease (CHD) patients underwent percutaneous coronary intervention (PCI) with sirolimus-eluting stent (SES).

Methods

Demographic data, clinical features, and laboratory tests of 398 CHD patients underwent PCI with SES were retrospectively reviewed. Coronary angiography was performed to evaluate coronary stenosis before PCI and in-stent restenosis at 1-year follow-up.

Results

There were 37 (9.3%) patients suffered restenosis, but 361 (90.7%) patients did not develop restenosis at 1-year follow-up. Demographic characteristic (age), cardiovascular risk factors (hypertension and hyperuricemia), biochemical indexes (fasting blood-glucose, total cholesterol, low density lipoprotein cholesterol (LDL-C) and high-sensitivity C-reactive protein (HsCRP)), cardiac function index (cardiac troponin I), lesion features (multivessel artery lesions, target lesion at left circumflex artery (LCX), two target lesions and length of target lesion), and operation procedure (length of stent) were correlated with higher restenosis risk. Moreover, age, hypertension, diabetes mellitus, LDL-C, HsCRP, and target lesion at LCX were independent predictive factors for raised restenosis risk. Based on these independent predictive factors, we established a restenosis risk prediction model, and receiver-operating characteristic curves displayed that this model exhibited an excellent predictive value for higher restenosis risk (areas under the curve 0.953 (95% CI 0.926–0.981)).

Conclusion

Our findings provide a new insight into the prediction for restenosis in CHD patients underwent PCI with SES.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Piccolo R, Giustino G, Mehran R, Windecker S (2015) Stable coronary artery disease: revascularisation and invasive strategies. Lancet 386(9994):702–713

    Article  Google Scholar 

  2. Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A (2016) Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med 4(13):256

    Article  Google Scholar 

  3. Zheng X, Zheng Y, Ma J, Zhang M, Zhang Y, Liu X, Chen L, Yang Q, Sun Y, Wu J, Yu B (2019) Effect of exercise-based cardiac rehabilitation on anxiety and depression in patients with myocardial infarction: a systematic review and meta-analysis. Heart Lung 48(1):1–7

    Article  Google Scholar 

  4. Beatty AL, Doll JA, Schopfer DW, Maynard C, Plomondon ME, Shen H, Whooley MA (2018) Cardiac rehabilitation participation and mortality after percutaneous coronary intervention: insights from the veterans affairs clinical assessment, reporting, and tracking program. J Am Heart Assoc 7(19):e010010

    Article  Google Scholar 

  5. Tian Y, Deng P, Li B, Wang J, Li J, Huang Y, Zheng Y (2019) Treatment models of cardiac rehabilitation in patients with coronary heart disease and related factors affecting patient compliance. Rev Cardiovasc Med 20(1):27–33

    Article  Google Scholar 

  6. Nazneen F, Herzog G, Arrigan DW, Caplice N, Benvenuto P, Galvin P, Thompson M (2012) Surface chemical and physical modification in stent technology for the treatment of coronary artery disease. J Biomed Mater Res B Appl Biomater 100(7):1989–2014

    Article  Google Scholar 

  7. Arafat M, Fouladian P, Blencowe A, Albrecht H, Song Y, Garg S (2019) Drug-eluting non-vascular stents for localised drug targeting in obstructive gastrointestinal cancers. J Control Release 308:209–231

    Article  CAS  Google Scholar 

  8. Zahn R, Hamm CW, Schneider S, Zeymer U, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Nienaber CA, Pfannebecker T, Senges J, German Cypher Stent R (2007) The Sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent registry. Clin Res Cardiol 96(8):548–556

    Article  CAS  Google Scholar 

  9. Mazin I, Paul G, Asher E (2019) Neoatherosclerosis - from basic concept to clinical implication. Thromb Res 178:12–16

    Article  CAS  Google Scholar 

  10. Ray GM, Nawarskas JJ, Frishman WH (2006) The paclitaxel-eluting stent in percutaneous coronary intervention: part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions. Cardiol Rev 14(3):143–150

    Article  Google Scholar 

  11. Yates DJ, Savage ML, Walters DL, Raffel OC (2016) Retrospective study of first-generation drug-eluting stents, second-generation drug-eluting stents and non-drug eluting stent methods in the treatment of native vessel in-stent restenosis in real-world clinical practice. Heart Lung Circ 25(4):342–351

    Article  Google Scholar 

  12. Farooq V, Gogas BD, Serruys PW (2011) Restenosis: delineating the numerous causes of drug-eluting stent restenosis. Circ Cardiovasc Interv 4(2):195–205

    Article  Google Scholar 

  13. Xiu WJ, Yang HT, Zheng YY, Ma YT, Xie X (2018) Drug-eluting balloons versus second-generation drug-eluting stents for treating in-stent restenosis in coronary heart disease after PCI: a meta-analysis. Cardiol Res Pract 2018:7658145

    Article  Google Scholar 

  14. Kastrati A, Dibra A, Mehilli J, Mayer S, Pinieck S, Pache J, Dirschinger J, Schomig A (2006) Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation 113(19):2293–2300

    Article  Google Scholar 

  15. Zhao LP, Xu WT, Wang L, Li H, Shao CL, Gu HB, Chan SP, Xu HF, Yang XJ (2015) Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up. Coron Artery Dis 26(1):5–10

    Article  Google Scholar 

  16. Wu Y, Fu X (2019) Comprehensive analysis of predictive factors for rapid angiographic stenotic progression and restenosis risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents implantation. J Clin Lab Anal 33(2):e22666

    Article  Google Scholar 

  17. Qian H, Luo Z, Xiao C, Chen J, Li D, Xu H, He P, Zhou X, Zhang T, Min X (2018) Red cell distribution width in coronary heart disease: prediction of restenosis and its relationship with inflammatory markers and lipids. Postgrad Med J 94(1115):489–494

    Article  CAS  Google Scholar 

  18. Obata JE, Nakamura T, Kitta Y, Saito Y, Sano K, Fujioka D, Kawabata K, Kugiyama K (2013) In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter. Catheter Cardiovasc Interv 82(6):E777–E787

    Article  Google Scholar 

  19. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH, American College of Cardiology F, American Heart Association Task Force on Practice G, Society for Cardiovascular A, Interventions (2013) 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv 82(4):E266–E355

    PubMed  Google Scholar 

  20. Bruining N, Sabate M, de Feyter PJ, Kay IP, Ligthart J, Disco C, Kutryk MJ, Roelandt JR, Serruys PW (1999) Quantitative measurements of in-stent restenosis: a comparison between quantitative coronary ultrasound and quantitative coronary angiography. Catheter Cardiovasc Interv 48(2):133–142

    Article  CAS  Google Scholar 

  21. Haase J, Escaned J, van Swijndregt EM, Ozaki Y, Gronenschild E, Slager CJ, Serruys PW (1993) Experimental validation of geometric and densitometric coronary measurements on the new generation Cardiovascular Angiography Analysis System (CAAS II). Catheter Cardiovasc Diagn 30(2):104–114

    Article  CAS  Google Scholar 

  22. Siontis GC, Piccolo R, Praz F, Valgimigli M, Raber L, Mavridis D, Juni P, Windecker S (2016) Percutaneous coronary interventions for the treatment of stenoses in small coronary arteries: a network meta-analysis. JACC Cardiovasc Interv 9(13):1324–1334

    Article  Google Scholar 

  23. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R (2007) Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27(7):1500–1510

    Article  CAS  Google Scholar 

  24. Nakazawa G, Nakano M, Otsuka F, Wilcox JN, Melder R, Pruitt S, Kolodgie FD, Virmani R (2011) Evaluation of polymer-based comparator drug-eluting stents using a rabbit model of iliac artery atherosclerosis. Circ Cardiovasc Interv 4(1):38–46

    Article  CAS  Google Scholar 

  25. Park HJ, Kim HY, Lee JM, Choi YS, Park CS, Kim DB, Her SH, Koh YS, Park MW, Kwon BJ, Kim PJ, Chang K, Chung WS, Seung KB (2012) Randomized comparison of the efficacy and safety of zotarolimus-eluting stents vs. sirolimus-eluting stents for percutaneous coronary intervention in chronic total occlusion--CAtholic Total Occlusion Study (CATOS) trial. Circ J 76(4):868–875

    Article  CAS  Google Scholar 

  26. Ge L, Iakovou I, Cosgrave J, Chieffo A, Montorfano M, Michev I, Airoldi F, Carlino M, Melzi G, Sangiorgi GM, Corvaja N, Colombo A (2005) Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions. Eur Heart J 26(11):1056–1062

    Article  CAS  Google Scholar 

  27. Chatani K, Muramatsu T, Tsukahara R, Ito Y, Ishimori H, Hirano K, Nakano M, Yamawaki M, Araki M, Sakurai M, Iuchi K, Nozawa T, Inoue H (2009) Predictive factors of re-restenosis after repeated sirolimus-eluting stent implantation for SES restenosis and clinical outcomes after percutaneous coronary intervention for SES restenosis. J Interv Cardiol 22(4):354–361

    Article  Google Scholar 

  28. Ishii H, Toriyama T, Aoyama T, Takahashi H, Amano T, Hayashi M, Tanaka M, Kawamura Y, Yasuda Y, Yuzawa Y, Maruyama S, Matsuo S, Matsubara T, Murohara T (2009) Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis. Circ Cardiovasc Interv 2(6):513–518

    Article  CAS  Google Scholar 

  29. Asamasu-Sato S, Mita M, Ogawa R, Isaka M, Saito M (2007) Analysis of clinical factors that influence re-stenosis after percutaneous coronary stenting. Yakugaku Zasshi 127(8):1309–1315

    Article  CAS  Google Scholar 

  30. Mohan S, Dhall A (2010) A comparative study of restenosis rates in bare metal and drug-eluting stents. Int J Angiol 19(2):e66–e72

    Article  Google Scholar 

  31. Aronson D (2002) Potential role of advanced glycosylation end products in promoting restenosis in diabetes and renal failure. Med Hypotheses 59(3):297–301

    Article  CAS  Google Scholar 

  32. Ping S, Liu S, Zhou Y, Li Z, Li Y, Liu K, Bardeesi AS, Wang L, Chen J, Deng L, Wang J, Wang H, Chen D, Zhang Z, Sheng P, Li C (2017) Protein disulfide isomerase-mediated apoptosis and proliferation of vascular smooth muscle cells induced by mechanical stress and advanced glycosylation end products result in diabetic mouse vein graft atherosclerosis. Cell Death Dis 8(5):e2818

    Article  CAS  Google Scholar 

  33. Li C, Shen Y, Xu R, Dai Y, Chang S, Lu H, Dong Z, Deng J, Qian J, Ge J (2018) Evaluation of Preprocedural laboratory parameters as predictors of drug-eluting stent restenosis in coronary chronic total occlusion lesions. Angiology:3319717752245

  34. Li JJ, Yan HB, Xiang XP, Qin XW, Zhang CY (2009) Comparison of changes in early inflammatory markers between sirolimus- and paclitaxel-eluting stent implantation. Cardiovasc Drugs Ther 23(2):137–143

    Article  Google Scholar 

  35. Nakazawa KR, Wengerter SP, Power JR, Lookstein RA, Tadros RO, Ting W, Faries PL, Vouyouka AG (2017) Preoperative inflammatory status as a predictor of primary patency after femoropopliteal stent implantation. J Vasc Surg 66(1):151–159

    Article  Google Scholar 

  36. Naganuma T, Chieffo A, Basavarajaiah S, Takagi K, Costopoulos C, Latib A, Carlino M, Montorfano M, Bernelli C, Nakamura S, Colombo A (2013) Single-stent crossover technique from distal unprotected left main coronary artery to the left circumflex artery. Catheter Cardiovasc Interv 82(5):757–764

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, China

    Jiayu Zhao, Xun Wang, Haiyan Wang, Ying Zhao & Xianghua Fu

Authors
  1. Jiayu Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Haiyan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ying Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xianghua Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xianghua Fu.

Ethics declarations

This study was approved by the Institutional Review Board of The Second Hospital of Hebei Medical University, and the written informed consents were provided by patients or their guardians.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, J., Wang, X., Wang, H. et al. Occurrence and predictive factors of restenosis in coronary heart disease patients underwent sirolimus-eluting stent implantation. Ir J Med Sci 189, 907–915 (2020). https://doi.org/10.1007/s11845-020-02176-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-020-02176-9

Keywords

Search

Navigation